EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Opioid Withdrawal Following Intrathecal Morphine Pump Explantation Managed with a Structured Oral Opioid Taper: A Case Study

Jamal Hasoon, Preetash Sundar, Omar Viswanath, Alan D Kaye, Ivan Urits, Grant H Chen

Psychopharmacology Bulletin · 29.10.2026 · 56 (4) · 173-180

DOI: 10.64719/pb.21639 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Psychopharmacology Bulletin, online erschienen am 29.10.2026. Verfasst von Jamal Hasoon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hasoon, MD, Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School at UTHealth Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Morphine, Substance Withdrawal Syndrome, Chronic Pain. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intrathecal (IT) opioid therapy is an established treatment for refractory chronic pain. Abrupt discontinuation of intrathecal opioids, especially following pump explantation, can precipitate clinically significant opioid withdrawal. Evidence guiding optimal management of withdrawal in this setting remains limited. Case Presentation We report the case of a female patient with chronic pain related to prior lumbar spine and hip surgery who underwent explantation of an intrathecal morphine pump due to logistical barriers to routine refill appointments. Following explantation, she developed classic opioid withdrawal symptoms including worsening pain, nausea, chills, diaphoresis, and diarrhea. She remained clinically stable without evidence of infection or a surgical complication. Treatment consisted of gabapentin 300 mg four times daily and a structured four-week taper of short-acting oxycodone, followed by tramadol 50 mg three times daily as needed for 10 days. All opioids were subsequently discontinued, and gabapentin was progressively tapered without recurrent withdrawal symptoms.

Conclusion

This case demonstrates that a structured, individualized oral opioid taper combined with adjunctive nonopioid therapy may be an effective outpatient strategy for selected, clinically stable patients experiencing withdrawal after intrathecal opioid discontinuation. Since intrathecal-to-oral opioid conversions are highly variable, treatment should be guided by symptoms, tolerability, and close clinical reassessment rather than reliance on a single equianalgesic ratio.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidMorphineSubstance Withdrawal SyndromeChronic PainDrug TaperingHumansFemaleGabapentinInfusion Pumps, ImplantableInjections, SpinalCyclohexanecarboxylic AcidsAminesgamma-Aminobutyric AcidAdministration, OralOxycodoneTramadolMiddle Aged

Stichwörter der Autor:innen

chronic paingabapentinintrathecal morphineopioidopioid taperopioid withdrawaltargeted drug delivery

Substanzen

Analgesics, OpioidGabapentinMorphineCyclohexanecarboxylic AcidsAminesgamma-Aminobutyric AcidOxycodoneTramadol

Autor:innen und Institutionen

  • Hasoon, MD, Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.
  • Sundar, BS, Brown University School of Public Health, Providence, RI, USA.
  • Viswanath, MD, Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School at UTHealth Houston, Houston, Texas, USA; Mountain View Headache and Spine Institute, Phoenix, AZ, USA.
  • Kaye, MD, PhD, Department of Anesthesiology, Louisiana State University Health Shreveport, Shreveport, LA, USA.
  • Urits, MD, Department of Pain Medicine, SouthCoast Physician Group, Wareham, MA.
  • Chen, MD, Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.

Zitieren

APA

Hasoon, J., Sundar, P., Viswanath, O., Kaye, A. D., Urits, I., & Chen, G. H. (2026). Opioid Withdrawal Following Intrathecal Morphine Pump Explantation Managed with a Structured Oral Opioid Taper: A Case Study. Psychopharmacology Bulletin, 56(4), 173-180. https://doi.org/10.64719/pb.21639

Vancouver

Hasoon J, Sundar P, Viswanath O, Kaye AD, Urits I, Chen GH. Opioid Withdrawal Following Intrathecal Morphine Pump Explantation Managed with a Structured Oral Opioid Taper: A Case Study. Psychopharmacology Bulletin. 2026;56(4):173-180. doi:10.64719/pb.21639

BibTeX
@article{Hasoon2026,
  author = {Hasoon, Jamal and Sundar, Preetash and Viswanath, Omar and Kaye, Alan D and Urits, Ivan and Chen, Grant H},
  title = {Opioid Withdrawal Following Intrathecal Morphine Pump Explantation Managed with a Structured Oral Opioid Taper: A Case Study},
  journal = {Psychopharmacology Bulletin},
  year = {2026},
  volume = {56},
  number = {4},
  pages = {173--180},
  doi = {10.64719/pb.21639}
}
Kostenlos starten →